| Breakdown | TTM | Sep 2025 | Sep 2024 | Sep 2023 | Sep 2022 | Sep 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 148.94M | 116.80M | 95.61M | 83.81M | 66.10M | 40.68M |
| Gross Profit | 62.77M | 53.75M | 51.53M | 45.76M | 34.53M | 18.79M |
| EBITDA | 33.13M | 21.61M | 16.52M | 14.68M | 12.78M | 3.02M |
| Net Income | 19.73M | 11.89M | 8.30M | 7.76M | 6.59M | 366.00K |
Balance Sheet | ||||||
| Total Assets | 101.55M | 91.09M | 81.69M | 74.28M | 68.32M | 52.72M |
| Cash, Cash Equivalents and Short-Term Investments | 12.76M | 15.36M | 15.78M | 13.02M | 15.28M | 13.03M |
| Total Debt | 18.88M | 17.05M | 18.07M | 18.11M | 16.40M | 8.60M |
| Total Liabilities | 31.38M | 28.20M | 28.08M | 26.11M | 26.47M | 16.57M |
| Stockholders Equity | 70.17M | 62.90M | 53.61M | 48.17M | 41.84M | 36.14M |
Cash Flow | ||||||
| Free Cash Flow | 2.81M | 5.19M | 9.30M | 561.00K | 92.00K | -553.00K |
| Operating Cash Flow | 4.20M | 6.11M | 11.88M | 3.28M | 2.94M | 1.08M |
| Investing Cash Flow | -1.44M | -914.00K | -3.21M | -3.00M | -3.75M | -1.63M |
| Financing Cash Flow | -266.00K | -5.62M | -5.91M | -2.53M | 3.06M | -2.30M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | £190.90M | 9.67 | 29.66% | 3.00% | 43.98% | 97.22% | |
68 Neutral | £37.71M | 9.68 | 8.41% | 11.65% | -3.78% | -43.43% | |
67 Neutral | £242.70M | 22.19 | 9.96% | 3.78% | 1.57% | -70.10% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
55 Neutral | £105.61M | 17.02 | 5.20% | 5.24% | 11.23% | -59.12% | |
51 Neutral | £210.63M | -0.39 | 125.82% | ― | 1.56% | -185.45% | |
46 Neutral | £99.57M | 18.87 | 22.27% | 1.48% | 8.14% | 81.96% |